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Common fragile sites have been proposed to play a mechanistic role in chromosome translocations and other rearrangements
in cancer cells in vivo based on their behavior in vitro and their co-localization with cancer translocation breakpoints. This
hypothesis has been the subject of controversy, because associations have been made at the chromosomal level and because
of the large number of both fragile sites and cancer chromosome breakpoints. Tests of this hypothesis at the molecular level
are now possible with the cloning of common fragile site loci and the use of fragile site clones in the analysis of rearranged
chromosomes. FRA3B, the most frequently seen common fragile site, lies within the large FHIT gene. It is now well established
that this region is the site of frequent, large intragenic deletions and aberrant transcripts in a number of tumors and tumor
cell lines. In contrast, only one tumor-associated translocation involving the FHIT gene has been reported. We have found
translocations in both homologs of chromosome 3 in an early-passage esophageal adenocarcinoma cell line. This cell line
showed no normal FHIT transcripts by reverse transcription polymerase chain reaction. Subsequent chromosome analysis
showed translocations of the short arms of both homologs of chromosome 3: t(3;16) and t(3;4). The breakpoints of both
translocations were shown by fluorescence in situ hybridization and polymerase chain reaction to be in the FHIT gene, at or
near the center of the fragile site region. Using rapid amplification of cDNA ends with FHIT primers, a noncoding chimeric
transcript resulting from t(3;16) was identified. These data provide direct support for the hypothesis that FRA3B, and likely
other common fragile sites, may be “hot spots” for translocations in certain cancers, as they are for deletions, and that such
translocations have the potential to form abnormal chimeric transcripts. In addition, the results suggest selection for loss of
a functional FHIT gene by the translocation events. © 2001 Wiley-Liss, Inc.
INTRODUCTION
It is well established that common fragile sites are
loci that are especially sensitive to forming gaps or
occasionally breaks on metaphase chromosomes
when cultured with aphidicolin or under conditions
of folate stress (Glover, 1998). Consistent with a pos-
sible role in chromosome rearrangements in vivo,
they also have been shown in cells cultured in vitro to
be “hot spots” for translocations and deletions (Glov-
er and Stein, 1988; Wang et al., 1997), sister-chroma-
tid exchanges (SCEs) (Glover and Stein, 1987), DNA
integration (Rassool et al., 1991), and DNA breaks
associated with gene amplification in CHO cells (Co-
quelle et al., 1997). The association between the
location of common fragile sites and sites of chromo-
some translocation or other rearrangements in cancer
and leukemia was noted by many investigators when
common fragile sites were first characterized (Glover
et al., 1984; Hecht and Glover, 1984; Le Beau and
Rowley, 1984; Yunis and Soreng, 1984). This coinci-
dent location of fragile sites and recurrent cancer-
related breakpoints led to the hypothesis that there is
a mechanistic relationship between the two. This
hypothesis was advanced most noticeably by Yunis
and Soreng (1984), who promoted it by noting a large
number of such associations in numerous leukemias,
lymphomas, and solid tumors. This hypothesis, how-
ever, has been the subject of controversy, owing to
the sheer number of both breakpoints and fragile
sites and the fact that the location of fragile sites was
based on conventional cytogenetic assignments and
not on molecular maps.
The cloning of common fragile site regions has
allowed more sensitive molecular analysis of their
behavior in cancer cells. The FRA3B fragile site
lies within the FHIT gene, which has been shown
to be mutated by large intragenic deletions and to
produce aberrant transcripts in a variety of tumor
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cells (Sozzi et al., 1998). The deletions suggest that
instability at the fragile site is mechanistically re-
sponsible for the deletions and also that there is
selection for loss of functional FHIT alleles in these
tumor cells. Recent investigations of other com-
mon fragile sites show a similar pattern of deletion
in cancer cells, in agreement with the hypothesis
that this is a general feature of common fragile sites
(Huang et al., 1999; Mangelsdorf et al., 2000; Paige
et al., 2000). For the most part, the rearrangements
studied and reported to date are large deletions of
hundreds of kilobases.
Few attempts have been made to identify trans-
locations or other gross chromosomal rearrange-
ments at fragile sites, which, if found, would sup-
port original suggestions concerning fragile sites
and cancer-related chromosome rearrangements.
Only two translocations have been reported previ-
ously, with breakpoints shown to be in the FHIT/
FRA3B region. One of these, t(3;8)(p14.2;q24), was
a constitutional translocation associated with he-
reditary renal cell cancer in one family (Cohen et
al., 1979), which was found to result in a chimeric
transcript between FHIT and the TRC8 gene, a
putative patched family member (Gemmill et al.,
1998). The second was in a pleomorphic adenoma
of the thyroid gland, which resulted in the fusion of
FHIT and the HMGIC gene on chromosome 12
(Geurts et al., 1997). Recently, the FRA16D region
has been shown to contain a gene termed FOR,
with homology to the oxidoreductase gene family,
within which three of five previously mapped mul-
tiple myeloma translocation breakpoints are lo-
cated (Mangelsdorf et al., 2000).
We report here the finding of two different trans-
location breakpoints within FRA3B and the FHIT
gene in both homologs of chromosome 3 in an
early-passage esophageal adenocarcinoma cell line.
Characterization of the two translocations showed
one to result in a nonfunctional chimeric transcript
with sequences at 16p13.3. The second is a trans-
location to a region on distal 4p. These results
provide further evidence that fragile sites partici-
pate in translocations in tumor cells. Together with
earlier findings of translocations within fragile site
regions in cancers, they suggest that such events
may not be infrequent, and they provide a mecha-
nism for gene loss or formation of novel transcripts.
MATERIALS AND METHODS
Cell Lines
The BIC-1 adenocarcinoma cell line was estab-
lished from minced tumor tissue obtained from a
male patient who had undergone surgical resection
for a stage T3, N1, MO Barrett adenocarcinoma
and who had received no other preoperative treat-
ments, such as radiation or chemotherapy. The cell
line was grown in Dulbecco modified Eagle me-
dium with 15% fetal bovine serum and analyzed at
passages 8–10.
Cytogenetic Analysis and Fluorescence In Situ
Hybridization
Chromosome preparations and G-banding were
done by standard methods, and fluorescence in situ
hybridization (FISH) was done as previously de-
scribed (Dagenais et al., 1999). For FISH probes,
yeast artificial chromosome (YAC) y850A6 was
mapped to FRA3B as previously described (Wilke
et al., 1994), and YAC y750F1 was obtained from
Research Genetics (Huntsville, AL). To obtain a
FISH probe specific for FHIT exon 10, a human
DNA lambda library was screened with FHIT exon
10 cDNA as a probe by conventional filter hybrid-
ization. A 15-kb genomic fragment containing part
of intron 9, exon 10, and 39-flanking sequence was
isolated and used as a probe for FISH.
FISH probes for FHIT intron 5 were obtained by
screening of the CITB human bacterial artificial chro-
mosome (BAC) library (Research Genetics) by poly-
merase chain reaction (PCR) methods using primers
within intron 5. Clone 254E1 was identified by
screening with PCR primers (59-GAAGATGAG-
CAGCGTATGTTGC-39 and 59-TGTCCTAGGT-
GCTGAGGACAC-39), which are approximately 50
kb distal to exon 5. Clone 385N7 was identified using
PCR primers (59-GGATCTCTCATCCAACCT-
TCC-39 and 59-GATCCCTGGGGTGTAACTA-
TC-39), which are approximately 150 kb distal to
exon 5. Thus, BAC clone 254E1 contains proximal
intron 5 sequences, whereas clone 358N7 contains
sequences from the central region of intron 5.
Whole-chromosome paint probes to chromo-
somes 3 (Imagenetics, Framingham, MA), 4 (On-
cor, Gaithersburg, MD), and 16 (Oncor) were hy-
bridized separately and in combination according
to the manufacturer’s instructions. The chromo-
some 3 probe was directly labeled with Spectrum
Orange, and the chromosome 4 and 16 probes were
detected with fluorescein isothiocyanate–anti-
digoxigenin. Chromosomes were counterstained
with 496-diamidino-2-phenylindole.
Genomic PCR
Genomic DNA was extracted from the BIC-1 cell
line using the QIAamp Tissue Kit (Qiagen, Valencia,
CA). PCR was done using markers from FHIT intron
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4 (D3S1481), FHIT intron 5 (D3S4103), and FHIT
exon 5 (forward primer: 59-ATGTCGTTCAGATT-
TGGCC-39; reverse primer: 59-CTGGTACCACAG-
GTTTCCTA-39).
Reverse Transcription-PCR and Rapid
Amplification of cDNA Ends
Total RNA was isolated from the BIC-1 cell line
using Trizol (Gibco BRL, Gaithersburg, MD) ac-
cording to the manufacturer’s instructions. Reverse
transcription-PCR (RT-PCR) was done using
primers from FHIT exons 1 and 10. Three pairs of
primers were used for PCR, with the first pair
containing the exon 1 forward primer (59-CTTTT-
TGCCCTCTGTTCCCG-39) and exon 1 reverse
primer (59-GGATGTTGACAGCTGGGAATG-
39). The second pair contained the exon 10 forward
primer (59-CCTGAATTCCAGCAAAAGAGC-39)
and the exon 10 reverse primer (59-GCAGCAGAG-
GAAGGAAGTTTA-39). The third pair contained
the exon 1 forward primer (59-CTTTTTGCCCT-
CTGTTCCCG-39) and the exon 10 reverse primer
(59-TCACTGGTTGAAGAATACAGG-39).
We used the 39 RACE system for the rapid
amplification of cDNA ends (Gibco BRL). Briefly,
first-strand cDNA was reverse-transcribed from 2
mg of total RNA, using the oligo dT-adapter primer
supplied by the manufacturer. For 39 RACE, am-
plification of the target cDNA was done using a
forward primer to exon 1 of FHIT (59-CTTTTT-
GCCCTCTGTTCCCG-39) and a reverse primer
complementary to the adapter. 59 RACE was sim-
ilarly done using a 59 RACE system (Gibco BRL).
First-strand cDNA was reverse-transcribed using a
primer specific for FHIT exon 10 (59-TGCCTGT-
CTGAGCCGTTTAGGTCTAGG-39). A poly-C
tail then was added to the purified first-strand
cDNA in a TdT tailing reaction. Amplification of
the target cDNA was performed with the 59 RACE
anchor primer containing poly-G (supplied by the
manufacturer) and a nested primer from FHIT
exon 10 (59-TCACTGGRRGAAGAATACAGG-
39). All RACE products were cloned into plasmid
vector pCR2.1 (Invitrogen, Carlsbad, CA).
Sequencing
All sequencing was done by the Sequencing
Core Laboratory at the University of Michigan us-
ing ABI 377 automated sequencers.
RESULTS
G-banded chromosome analysis of the early-pas-
sage BIC-1 esophageal adenocarcinoma cell line
showed a hyperdiploid karyotype with a number of
chromosomal rearrangements. The karyotype, as
determined by G-banding and FISH with FRA3B






Both homologs of chromosome 3 were rear-
ranged, with translocation breakpoints at or near
3p14.2 and reciprocal breakpoints at 4p16 and at
16p13 of an isodicentric chromosome 16. The
der(16) had undergone an additional rearrange-
ment, with the presence of additional material of
unknown origin translocated to 16p11 of the other
arm of the isodicentric chromosome. RT-PCR am-
plification of the entire FHIT transcript using prim-
ers from exons 1 and 10 resulted in no product,
whereas RT-PCR using primers within exons 1 and
10 separately gave fragments of the expected sizes
(data not shown). FISH with whole-chromosome
paint probes (not shown) indicated a reciprocal
translocation between 3p and der(16) and translo-
cation of chromosome 3 material to 4p. Chromo-
some 4 or 16 signal was not detected on the other
der(3) chromosome with the paint probes used.
These findings led us to look for translocations
within the FHIT/FRA3B region using region-spe-
cific YAC clones in FISH experiments. YAC
y850A6 extends from a region proximal (centro-
meric) to the FHIT locus to the proximal (59) end
of intron 5. YAC y750F1 extends from FHIT intron
4 to a region distal to the FHIT locus (Ohta et al.,
1996). Both YACs span FRA3B gaps on normal
metaphases. Using these YACs as probes on BIC-1
metaphase cells, y750F1 was found to span the
translocation breakpoints of both chromosome 3
homologs and showed the reciprocal translocation
breakpoints to be at 4p16 and 16p13 (Fig. 1). Be-
cause y750F1 extends distally past FHIT, a FHIT
exon 10 FISH probe also was used to confirm that
the breakpoints were indeed within the FHIT gene
(not shown). Exon 10 was translocated to the der(4)
and der(16) chromosomes, showing that the break-
points were between intron 4 and exon 10 of the
FHIT locus (not shown).
To define further the location of the breakpoints
within the FHIT/FRA3B region on chromosome 3,
we performed FISH with BAC clone probes from
within the large ('500 kb) intron 5 of FHIT and
genomic PCR with FHIT primers. The results
showed that BAC 254E1, containing proximal in-
tron 5 sequences, hybridized only to the der(4)
chromosome, whereas BAC 385N7 from the mid-
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dle of intron 5 hybridized to both the der(4) and
der(16) chromosomes (Fig. 1). Genomic PCR was
done using primers from FHIT intron 4 (D3S1481),
FHIT intron 5 (D3S4103), and FHIT exon 5. PCR
amplification of D3S1481 and D3S4103 gave frag-
ments of the expected sizes. PCR amplification
using FHIT exon 5 primers, however, resulted in
no fragments, suggesting that exon 5 is homozy-
gously deleted in BIC-1. This deletion was con-
firmed by Southern blot hybridization of BIC-1
DNA with an exon 5 probe (data not shown).
Taken together, the FISH and genomic PCR
data show that both homologs of chromosome 3 are
broken in the region from intron 4 to proximal to
intron 5, and both translocations are accompanied
by different deletions of the region around exon 5
(Fig. 2). The t(3;4) breakpoint lies proximal to
BAC 254E1 and is accompanied by a deletion that
encompasses FHIT exon 5. The t(3;16) breakpoint
is proximal to BAC 385N7 and is accompanied by
a larger deletion that encompasses exon 5 and the
region of intron 5 contained in BAC 254E1. The
proximal boundary of both translocations is FHIT
intron 4, or the proximal end of y750F1, since this
YAC spans both translocation breakpoints.
59 RACE from FHIT exon 10 showed only aber-
rant FHIT transcripts and no chimeric transcripts.
The aberrant transcript contained 93 nucleotides of
FHIT intron 8 with FHIT exons 9 and 10. The aber-
rant transcript may arise from a promoter-like region
in intron 8. Using 39 RACE, no transcripts containing
chromosome 4 sequences were noted, but novel chi-
meric transcripts resulting from the t(3;16) were iden-
tified. These contained exons 1, 2, and 4 of the FHIT
gene and additional sequences identical to GenBank
sequences from BAC clone 185J20, which map to
16p13.3. The chromosome 16 sequences were
spliced from three putative exons (TE1, TE2, and
TE3), with one chimeric transcript clone containing
TE1 and TE3, a second clone containing TE2 and
TE3, and a third containing only TE3 (Fig. 3). These
three chimeric transcripts appear to result from alter-
native splicing.
The sequence of the longest 39 RACE product
containing FHIT exons 1, 2, and 4 and cryptic
exons TE1 and TE3 from 16p13.3 is shown in
Figure 4. TE1, TE2, and TE3 contain stop codons
in all three reading frames, with the longest open
reading frame containing 52 amino acids. Northern
blot analysis with TE1, TE2, and TE3 as probes
did not detect a positive signal on a human multi-
ple tissue Northern blot (Clontech, Palo Alto, CA)
containing brain, heart, skeletal muscle, colon, thy-
mus, spleen, kidney, liver, small intestine, lung,
and peripheral blood leukocytes. Thus, TE1–TE3
does not appear to represent a functional gene but
Figure 1. Fluorescence in situ hybridization re-
sults show translocation breakpoints involving both
homologs of chromosome 3. a: YAC y850A6 hy-
bridizes to both der(3) chromosomes. b: YAC
y750F1 hybridizes to both der(3) chromosomes
and the der(4) and der(16) translocation partners,
showing that it spans both translocation break-
points. c: BAC 254E1 hybridizes only to the der(4)
chromosome, showing that it lies distal to one
chromosome 3 breakpoint and indicating a proxi-
mal intron 5 deletion in the homolog. d: BAC
358N7 hybridizes to both the der(4) and der(16)
chromosomes, showing that it lies distal to the
breakpoint on both chromosomes 3.
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rather a nonfunctional transcribed and spliced region
of chromosome 16 resulting from the translocation.
DISCUSSION
We have shown that both homologs of chromo-
some 3 are involved in translocations with break-
points in FHIT/FRA3B and at 4p16 and 16p13.3. All
available data indicate that the two translocations are
independent events, as opposed to a complex dupli-
cation of a single translocation event. The chromo-
some 3 breakpoints of both translocations are in the
region previously shown to be at the center of the
FRA3B region, as determined by the position of
aphidicolin-induced chromosome gaps on metaphase
chromosomes (Smith et al., 1992; Wilke et al., 1994),
and are accompanied by deletions encompassing
FHIT exon 5. Using RT-PCR, a noncoding chimeric
transcript was produced from the t(3;16) chromo-
some, which contained FHIT noncoding exons 1, 2,
and 4 and three cryptic exon regions from 16p13.3.
The RT-PCR results and FISH with whole-chromo-
some paint probes to chromosomes 3, 4, and 16 indi-
cate that the t(3;16) was reciprocal. Chromosome 4
material was not identified on the other der(3) ho-
molog by either FISH or RT-PCR. This finding
suggests that the translocation involving 4p16 was
nonreciprocal or, more likely, that the translocation
involved only the telomeric region of chromosome 4
and was not detected by the paint probe.
It is now well established that large genomic
deletions of up to hundreds of kilobases and aber-
rant transcripts are a common feature of mutations
within the FHIT gene in a variety of tumors (Sozzi
et al., 1998). The cells studied here were derived
from an esophageal adenocarcinoma, a tumor type
with increasing prevalence in the United States
(Devesa et al., 1998). We have previously shown
that FHIT deletions and aberrant transcripts are an
early and common event in esophageal adenocar-
cinoma and in the precursor metaplastic tissue of
Figure 3. Results of 39 RACE from FHIT exon 1. Three transcripts
were identified that contain FHIT exons 1, 2, and 4 and additional
sequences corresponding to BAC 185J20 from chromosome region
16p13.3. The three transcripts appear to result from alternative splicing
of the chromosome 16 cryptic exon sequences.
Figure 2. Map of the FHIT locus and position of fluorescence in situ hybridization probes used in this
study. The relative positions of the translocation breakpoints are shown, with the deleted regions indicated
by the dashed lines.
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Barrett esophagus (Michael et al., 1997). The loca-
tion of FHIT deletions in many tumors largely
coincides with the location of FRA3B, as defined
by chromosome gaps and breaks on metaphase
chromosome preparations. Thus, it is likely that
instability of the fragile site is mechanistically re-
sponsible for the deletions seen in FHIT in cancer
cells. Additional support for this hypothesis comes
from recent studies of other cloned fragile site
regions. FRA16D (Mangelsdorf et al., 2000; Paige
et al., 2000), FRA7G (Huang et al., 1996), and
FRAXB (Arlt et al., unpublished observations)
have been shown to contain internal deletions in
cancer cells or cell lines. Thus, mutation by large
deletion appears to be a common feature of com-
mon fragile sites in certain tumors.
In contrast to the large number of deletions seen in
FRA3B, only one other tumor-associated transloca-
tion has been reported to occur in the FHIT/FRA3B
region. This is a reciprocal t(3;12)(p14.2;q12) fortu-
itously found by examination of a chimeric transcript
produced between the HMGIC gene and FHIT 39
exons (Geurts et al., 1997). The findings reported
here suggest that these types of translocation events
could be more common than is realized at present,
since most investigations have looked for deletions in
the FHIT/FRA3B region only by PCR or Southern
blotting. There are many reported tumor karyotypes
with breakpoints in the 3p14 region. The application
of FISH or RT-PCR with FHIT/FRA3B probes and
primers to the examination of these and other tumors
would allow for a directed study to determine the
actual frequency of translocations or similar gross re-
arrangements.
Common fragile sites have been shown to be
frequent sites for translocations in vitro after expo-
sure of cultured cells to aphidicolin and folate
stress (Glover and Stein, 1988; Wang et al., 1997).
Together with the findings of fragile site–related
deletions and instability in tumor cells, this sug-
gests that instability at the fragile site is mechanis-
tically responsible for the translocations reported
here and for that shown by Geurts et al. (1997). In
both cases, the translocations result in inactivation
of the FHIT gene. We also found that both trans-
locations in the BIC-1 cell line were accompanied
by relatively large deletions of FHIT exon 5 and
proximal intron 5 sequences. The temporal order
and connection between the deletion and translo-
cation events cannot be determined, but the FHIT
gene could be inactivated by either the deletions or
the translocations. As with previously reported
FHIT deletions, instability at FRA3B could result
in translocations and deletions that may confer a
selective advantage for the cells. If the transloca-
tion and deletion events occurred sequentially,
however, there would be no selection for loss of
FHIT function during the latter event.
In summary, we have found both homologs of
chromosome 3 to be translocated, with breakpoints
in the FRA3B region, in an esophageal adenocar-
cinoma cell line. This finding lends support to early
suggestions regarding common fragile sites and tu-
mor-associated translocations. We suggest that
Figure 4. Sequence of chimeric transcripts resulting from t(3;16) and identified by 39 RACE. The longest
chimeric transcript containing TE1 and TE2 is shown. The 59 sequence (shaded) contains exons 1, 2, and
4 of FHIT. The 39 sequence contains cryptic exon sequences TE1 and TE3 (separated by the arrow) from
16p13.3. The amino acid sequence of the longest open reading frame is shown below the nucleotide
sequence.
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translocations involving FRA3B and other common
fragile sites, some with the potential for forming
chimeric transcripts with other genes, may be more
frequent than is realized currently.
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